Company intelligence / Profile preview

Lygos

Hayward, California, United Stateslygos.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lygos develops and commercializes bio-based specialty chemicals using engineered microbes. Its proprietary synthetic biology platform enables the conversion of plant-based sugars into high-value compounds such as malonic acid (Ecoteria™ malonates), replacing petrochemical processes with more sustainable alternatives. The company has demonstrated successful strain engineering collaborations (e.g., with Ginkgo Bioworks) to improve fermentation yields. It serves industries including agronomy, home care, personal care, water treatment, and fragrances.

Industry: Non-Drug Biotech

Partnerships

Ginkgo Bioworks (collaboration on strain/enzyme engineering)

Beyond the preview

Go deeper on Lygos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lygos.

Explore the full profile